bioRxivBiophysics
In silico study on the effects of disulfide bonds in ORF8 of SARS-CoV-2
Abstract
The COVID-19 epidemic, caused by virus SARS-CoV-2, has been a pandemic and threatening everyones health in the past two years. In SARS-CoV-2, the accessory protein ORF8 plays an important role in immune modulation. Here we present an in silico study on the effects of the disulfide bonds in ORF8, including the effects on the structures, the binding sites and free energy when ORF8 binds to the human leukocyte antigen (HLA-A). Using the explicit solvent Molecular Dynamics (MD) simulations, we collect the conformational ensembles on ORF8 with different disulfide bonds reduction schemes. With a new visualization technique on the local geometry, we analyze the effects of the disulfide bonds on the structure of ORF8. We find that the disulfide bonds have large influences on the loop regions of the surface. Moreover, by performing docking between HLA-A and the conformational ensembles of ORF8, we predict the preferred binding sites and find that most of them are little affected by the disulfide bonds.Further, we estimate the binding free energy between HLA-A and ORF8 with different disulfide bonds reductions. In the end, from the comparison with the available experimental results on the epitopes of ORF8, we validated our binding sites prediction. All the above observations may provide inspirations on inhibitor/drug design against ORF8 based on the binding pathway with HLA-A.
- organism: human
- assay: protein structure
- research focus: protein folding & dynamics
- approach: deep learning
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Structure of SARS-CoV-2 ORF8, a rapidly evolving coronavirus protein implicated in immune evasion
T. G. Flower, C. Z. Buffalo, … J. H. Hurley·bioRxiv·Aug 27, 2020
- A modified ACE2 peptide mimic to block SARS-CoV2 entry
S. Saurabh, S. S. Purohit·bioRxiv·May 7, 2020
- D155Y Substitution of SARS-CoV-2 ORF3a Weakens Binding with Caveolin-1
Suchetana Gupta, Ditipriya Mallick, … Siddhartha S. Jana·Computational and Structural Biotechnology JournalPeer-reviewed·Jan 1, 2022
- Impact of Thiol-Disulfide Balance on the Binding of Covid-19 Spike Protein with Angiotensin Converting Enzyme 2 Receptor
S. Bhattacharyya, S. Hati·bioRxiv·May 7, 2020
- LL-37 fights SARS-CoV-2: The Vitamin D-Inducible Peptide LL-37 Inhibits Binding of SARS-CoV-2 Spike Protein to its Cellular Receptor Angiotensin Converting Enzyme 2 In Vitro
A. Roth, S. Luetke, … A. R. Klatt·bioRxiv·Dec 2, 2020
- Computational optimization of the SARS-CoV-2 receptor-binding-motif affinity for human ACE2
S. Polydorides, G. Archontis·Biophysical JournalPeer-reviewed·Jul 1, 2021